Quantification of the prevalence of harms in healthcare related to drug treatment: reflections regarding the use of definitions developed for other settings to estimate the magnitude of the problem.
The prevalence of harms in healthcare related to drug treatment is often quantified using terms developed for pharmacovigilance and pharmaceutical care. In this overview, we guide through the definitions and the settings for which they were developed, with the underlying intention to facilitate the...
| Published in: | European Journal of Clinical Pharmacology Vol. 81; no. 1; pp. 173 - 181 |
|---|---|
| Main Authors: | , |
| Format: | review tables/charts Journal Article |
| Published: |
Springer Nature
Jan2025
|
| Online Access: | View this record in EBSCOhost |